http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-213101-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate | 1992-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f1a2bd279b529b16e0f4eb77020dbb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_459f14a95bcaa4d55b000ea6cb2f582d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18415aa8c5b5fd3c54f2bccc8a160bb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bab2ae31879484772018237a41bb81a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd19dc721b5296346b0f6fc177a987a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cb3729b65365bcb045a0eea5415c2ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ec428fb602912056b43b5773543b8c0 |
| publicationDate | 1997-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-213101-B |
| titleOfInvention | Process for producing pharmaceutical composition of synergetic gastrocitoprotective activity, containing ranitidine and derivative of the salicylic acid |
| abstract | The present invention relates to a gastrocytoprotective pharmaceutical composition containing as active agents a compound of general formula (I), wherein R means hydrogen or a C1-4alkyl group; R<1> stands for: hydroxyl group; C1-4alkoxy group; or a group of general formula (A), wherein R<2> means hydrogen or benzyl group; and R<3> means a C1-4alkyl group; or stands for a group of general formula (B), wherein R<4> means a C1-4alkyl group, and ranitidine in a weight ratio of 10:1 to 1:10 together with carriers and auxiliaries known per se, and to a process for the preparation thereof. A favourable active agent of general formula (I) is e.g. methyl 4-(3-carboxy-4-hydroxyphenyl)-4-oxo-(2E)-butenoate. The combination of the above active agents according to the invention exerts also an antibacterial effect (against the Helicobacter pylori strain). |
| priorityDate | 1992-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.